Existence, Uniqueness, and Stability of Solutions for Nabla Fractional Difference Equations
Fractal and Fractional · 08.10.2024 · 8 (10) · 591
DOI: 10.3390/fractalfract8100591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fractal and Fractional, online erschienen am 08.10.2024. Verfasst von Nikolay D. Dimitrov und 1 weiteren Autor:innen. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria.
Abstract (Originalsprache)
In this paper, we study a class of nabla fractional difference equations with multipoint summation boundary conditions. We obtain the exact expression of the corresponding Green’s function and deduce some of its properties. Then, we impose some sufficient conditions in order to ensure existence and uniqueness results. Also, we establish some conditions under which the solution to the considered problem is generalized Ulam–Hyers–Rassias stable. In the end, some examples are included in order to illustrate our main results.
Förderung
- European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria
Zitieren
APA
Dimitrov, N. D., & Jonnalagadda, J. M. (2024). Existence, Uniqueness, and Stability of Solutions for Nabla Fractional Difference Equations. Fractal and Fractional, 8(10), 591. https://doi.org/10.3390/fractalfract8100591
Vancouver
Dimitrov ND, Jonnalagadda JM. Existence, Uniqueness, and Stability of Solutions for Nabla Fractional Difference Equations. Fractal and Fractional. 2024;8(10):591. doi:10.3390/fractalfract8100591
BibTeX
@article{Dimitrov2024,
author = {Dimitrov, Nikolay D. and Jonnalagadda, Jagan Mohan},
title = {Existence, Uniqueness, and Stability of Solutions for Nabla Fractional Difference Equations},
journal = {Fractal and Fractional},
year = {2024},
volume = {8},
number = {10},
pages = {591},
doi = {10.3390/fractalfract8100591}
}
EUVIMED